BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 37561226)

  • 1. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.
    Osterman A; Krenn F; Iglhaut M; Badell I; Lehner A; Späth PM; Stern M; Both H; Bender S; Muenchhoff M; Graf A; Krebs S; Blum H; Grimmer T; Durner J; Czibere L; Dächert C; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Oct; 212(5):307-322. PubMed ID: 37561226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.
    Krenn F; Dächert C; Badell I; Lupoli G; Öztan GN; Feng T; Schneider N; Huber M; Both H; Späth PM; Muenchhoff M; Graf A; Krebs S; Blum H; Durner J; Czibere L; Kaderali L; Keppler OT; Baldauf HM; Osterman A
    Med Microbiol Immunol; 2023 Oct; 212(5):323-337. PubMed ID: 37561225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
    Osterman A; Badell I; Dächert C; Schneider N; Kaufmann AY; Öztan GN; Huber M; Späth PM; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Czibere L; Durner J; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Feb; 212(1):13-23. PubMed ID: 36370197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of "Variants of Concern": Implications for Clinical Use.
    Gourgeon A; Soulier A; Audureau É; Khouider S; Galbin A; Langlois C; Bouvier-Alias M; Rodriguez C; Chevaliez S; Pawlotsky JM; Fourati S
    Microbiol Spectr; 2022 Aug; 10(4):e0115722. PubMed ID: 35862982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired detection of omicron by SARS-CoV-2 rapid antigen tests.
    Osterman A; Badell I; Basara E; Stern M; Kriesel F; Eletreby M; Öztan GN; Huber M; Autenrieth H; Knabe R; Späth PM; Muenchhoff M; Graf A; Krebs S; Blum H; Durner J; Czibere L; Dächert C; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2022 Jun; 211(2-3):105-117. PubMed ID: 35187580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.
    Leuzinger K; Roloff T; Egli A; Hirsch HH
    Microbiol Spectr; 2022 Aug; 10(4):e0200622. PubMed ID: 35943268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Clinical Performance of InteliSwab
    Fischl MJ; Young J; Kardos K; Roehler M; Miller T; Wooten M; Holmes N; Gula N; Baglivo M; Steen J; Zelenz N; Joyee AG; Munster V; Weishampel Z; Yinda CK; Rouse KG; Gvozden C; Wever D; Yanez G; Anderson M; Yu S; Bearie B; Young S; Berry JD
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant.
    Bekliz M; Adea K; Puhach O; Perez-Rodriguez F; Marques Melancia S; Baggio S; Corvaglia AR; Jacquerioz F; Alvarez C; Essaidi-Laziosi M; Escadafal C; Kaiser L; Eckerle I
    Microbiol Spectr; 2022 Aug; 10(4):e0085322. PubMed ID: 35938792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Four Strategies for SARS-CoV-2 Detection: Characteristics and Prospects.
    Chen Y; Ma Y; Han Y; Diao Z; Chang L; Li J; Zhang R
    Microbiol Spectr; 2022 Dec; 10(6):e0214322. PubMed ID: 36287010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern.
    Bornemann L; Kaup O; Kleideiter J; Ruprecht B; Hoyer A; Panning M; Bornemann R; Wehmeier M
    Clin Microbiol Infect; 2023 Aug; 29(8):1085.e1-1085.e8. PubMed ID: 37182639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.
    Sah R; Rais MA; Mohanty A; Chopra H; Chandran D; Bin Emran T; Dhama K
    Int J Surg Open; 2023 Jun; 55():100625. PubMed ID: 37255735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant.
    Bayart JL; Degosserie J; Favresse J; Gillot C; Didembourg M; Djokoto HP; Verbelen V; Roussel G; Maschietto C; Mullier F; Dogné JM; Douxfils J
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays.
    Anderson M; Holzmayer V; Harris B; Hodges A; Olivo A; Fortney T; Goldstein Y; Hirschhorn J; Pytel D; Faron ML; Cloherty G; Rodgers MA
    J Clin Virol; 2023 Sep; 166():105532. PubMed ID: 37459763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay.
    Ippoliti C; De Maio F; Santarelli G; Marchetti S; Vella A; Santangelo R; Sanguinetti M; Posteraro B
    Microbiol Spectr; 2022 Aug; 10(4):e0099022. PubMed ID: 35863025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.
    Zhao Q; Wang X; Zhang Z; Liu X; Wang P; Cao J; Liang Q; Qu J; Zhou M
    J Med Virol; 2023 Jul; 95(7):e28932. PubMed ID: 37403923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
    Sakai-Tagawa Y; Yamayoshi S; Halfmann PJ; Wilson N; Bobholz M; Vuyk WC; Wei W; Ries H; O'Connor DH; Friedrich TC; Sordillo EM; van Bakel H; Simon V; Kawaoka Y
    J Med Virol; 2023 May; 95(5):e28788. PubMed ID: 37212288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.
    La Rosa G; Brandtner D; Bonanno Ferraro G; Veneri C; Mancini P; Iaconelli M; Lucentini L; Del Giudice C; Orlandi L; ; Suffredini E
    Sci Total Environ; 2023 May; 873():162339. PubMed ID: 36813191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Omicron variant sublineage BA.2.75 on the OnSite COVID-19 Ag Rapid Test: the applicability of rapid antigen test with universal transport media.
    Okada PA; Nuchnoi P; Buayai K; Phuygun S; Thongpramul N; Plabplueng C; Rojanawiwat A; Uppapong B; Sirilak S
    Infect Dis (Lond); 2024 Feb; 56(2):138-144. PubMed ID: 37970722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.